News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI Caitlin E. Cox November 04, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Conference News TCT 2022 Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL Yael L. Maxwell September 19, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2020 MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI Michael O'Riordan October 17, 2020
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020
News Conference News TCT 2020 MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions Shelley Wood October 15, 2020
News Conference News TCT 2019 Predicting Final Valve Position After TAVR: Different Devices, Different Success Michael O'Riordan October 07, 2019
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights Shelley Wood September 23, 2018
News Conference News TCT 2018 SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia Yael L. Maxwell September 23, 2018
Presentation TCT 2018 TCT-74: SCOUT Study: Trialign results at 30 days from combined US and EU cohort for the treatment of functional TR Presenter: Rebecca T. Hahn, Jose Luis Navia, Maurizio Taramasso, Christopher U. Meduri September 21, 2018
News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016